chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia
Clinical narrative: Heart arrhythmia; This is a spontaneous report from a contactable consumer (patient herself). A 24-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine), via an unspecified route of administration in the right arm on 08Mar2021 at 11:00 AM as a single dose for COVID-19 immunisation. The patient had no other vaccines in four weeks, did not have COVID prior to the vaccination, was not tested for COVID after the vaccination, had no known allergies, and no other medical history. There were no concomitant medications. The patient experienced heart arrhythmia on 09Mar202. Therapeutic measures were taken as a result of heart arrhythmia which included Beta blocker/s. Outcome of the event was unknown.  Information about the lot/batch number has been requested.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Chills, Dehydration, Dyspnoea, Histamine level increased
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; high levels of histamine; hives on back and chest; shortness of breath; blood pressure of 80/50; pneumonia; fever; chills; migraine; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205, expiry date: unknown), via an unspecified route of administration in the right arm, on 26Feb2021 14:30, as single dose, for covid-19 immunization, at a health department. Medical history included known allergies to latex and egg whites. The patient did not have COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccines in 4 weeks. On 26Feb2021 at 17:00, 3 hours after the vaccine, the patient experienced fever, chills and migraine which went on for 4 nights (as reported). On 03Mar2021 (reported as "fifth night"), the patient started to have high levels of histamine, hives on her back and chest and shortness of breath for three days (as reported). In Mar2021 (reported as "by the weekend"), the patient went to urgent care, underwent x-ray of chest, and had pneumonia. In Mar2021 (reported as "Monday"), the patient came back with blood pressure of 80/50 and was sent to the emergency room (ER). It was reported that the events pneumonia, fever, chills, migraine, high levels of histamine, hives on back and chest, shortness of breath and blood pressure of 80/50 required physician office and emergency room visits; treatment for these events included fluids, potassium and antibiotics (unspecified). On 06Mar2021, the patient underwent COVID nasal swab which resulted to positive. The patient recovered from events fever, chills and migraine on 02Mar2021; and from high levels of histamine, hives on her back and chest and shortness of breath on 06Mar2021. The outcome of the events pneumonia, "blood pressure of 80/50" and "COVID-19 confirmed by positive COVID-19 test" was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Migraine, Pneumonia, Pulmonary oedema, Pyrexia
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; high levels of histamine; hives on back and chest; shortness of breath; blood pressure of 80/50; pneumonia; fever; chills; migraine; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205, expiry date: unknown), via an unspecified route of administration in the right arm, on 26Feb2021 14:30, as single dose, for covid-19 immunization, at a health department. Medical history included known allergies to latex and egg whites. The patient did not have COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccines in 4 weeks. On 26Feb2021 at 17:00, 3 hours after the vaccine, the patient experienced fever, chills and migraine which went on for 4 nights (as reported). On 03Mar2021 (reported as "fifth night"), the patient started to have high levels of histamine, hives on her back and chest and shortness of breath for three days (as reported). In Mar2021 (reported as "by the weekend"), the patient went to urgent care, underwent x-ray of chest, and had pneumonia. In Mar2021 (reported as "Monday"), the patient came back with blood pressure of 80/50 and was sent to the emergency room (ER). It was reported that the events pneumonia, fever, chills, migraine, high levels of histamine, hives on back and chest, shortness of breath and blood pressure of 80/50 required physician office and emergency room visits; treatment for these events included fluids, potassium and antibiotics (unspecified). On 06Mar2021, the patient underwent COVID nasal swab which resulted to positive. The patient recovered from events fever, chills and migraine on 02Mar2021; and from high levels of histamine, hives on her back and chest and shortness of breath on 06Mar2021. The outcome of the events pneumonia, "blood pressure of 80/50" and "COVID-19 confirmed by positive COVID-19 test" was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; high levels of histamine; hives on back and chest; shortness of breath; blood pressure of 80/50; pneumonia; fever; chills; migraine; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205, expiry date: unknown), via an unspecified route of administration in the right arm, on 26Feb2021 14:30, as single dose, for covid-19 immunization, at a health department. Medical history included known allergies to latex and egg whites. The patient did not have COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccines in 4 weeks. On 26Feb2021 at 17:00, 3 hours after the vaccine, the patient experienced fever, chills and migraine which went on for 4 nights (as reported). On 03Mar2021 (reported as "fifth night"), the patient started to have high levels of histamine, hives on her back and chest and shortness of breath for three days (as reported). In Mar2021 (reported as "by the weekend"), the patient went to urgent care, underwent x-ray of chest, and had pneumonia. In Mar2021 (reported as "Monday"), the patient came back with blood pressure of 80/50 and was sent to the emergency room (ER). It was reported that the events pneumonia, fever, chills, migraine, high levels of histamine, hives on back and chest, shortness of breath and blood pressure of 80/50 required physician office and emergency room visits; treatment for these events included fluids, potassium and antibiotics (unspecified). On 06Mar2021, the patient underwent COVID nasal swab which resulted to positive. The patient recovered from events fever, chills and migraine on 02Mar2021; and from high levels of histamine, hives on her back and chest and shortness of breath on 06Mar2021. The outcome of the events pneumonia, "blood pressure of 80/50" and "COVID-19 confirmed by positive COVID-19 test" was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Body temperature, COVID-19, Chest X-ray, Chills
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; high levels of histamine; hives on back and chest; shortness of breath; blood pressure of 80/50; pneumonia; fever; chills; migraine; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205, expiry date: unknown), via an unspecified route of administration in the right arm, on 26Feb2021 14:30, as single dose, for covid-19 immunization, at a health department. Medical history included known allergies to latex and egg whites. The patient did not have COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccines in 4 weeks. On 26Feb2021 at 17:00, 3 hours after the vaccine, the patient experienced fever, chills and migraine which went on for 4 nights (as reported). On 03Mar2021 (reported as "fifth night"), the patient started to have high levels of histamine, hives on her back and chest and shortness of breath for three days (as reported). In Mar2021 (reported as "by the weekend"), the patient went to urgent care, underwent x-ray of chest, and had pneumonia. In Mar2021 (reported as "Monday"), the patient came back with blood pressure of 80/50 and was sent to the emergency room (ER). It was reported that the events pneumonia, fever, chills, migraine, high levels of histamine, hives on back and chest, shortness of breath and blood pressure of 80/50 required physician office and emergency room visits; treatment for these events included fluids, potassium and antibiotics (unspecified). On 06Mar2021, the patient underwent COVID nasal swab which resulted to positive. The patient recovered from events fever, chills and migraine on 02Mar2021; and from high levels of histamine, hives on her back and chest and shortness of breath on 06Mar2021. The outcome of the events pneumonia, "blood pressure of 80/50" and "COVID-19 confirmed by positive COVID-19 test" was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Histamine level, Histamine level increased, Hypotension, Migraine
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; high levels of histamine; hives on back and chest; shortness of breath; blood pressure of 80/50; pneumonia; fever; chills; migraine; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205, expiry date: unknown), via an unspecified route of administration in the right arm, on 26Feb2021 14:30, as single dose, for covid-19 immunization, at a health department. Medical history included known allergies to latex and egg whites. The patient did not have COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccines in 4 weeks. On 26Feb2021 at 17:00, 3 hours after the vaccine, the patient experienced fever, chills and migraine which went on for 4 nights (as reported). On 03Mar2021 (reported as "fifth night"), the patient started to have high levels of histamine, hives on her back and chest and shortness of breath for three days (as reported). In Mar2021 (reported as "by the weekend"), the patient went to urgent care, underwent x-ray of chest, and had pneumonia. In Mar2021 (reported as "Monday"), the patient came back with blood pressure of 80/50 and was sent to the emergency room (ER). It was reported that the events pneumonia, fever, chills, migraine, high levels of histamine, hives on back and chest, shortness of breath and blood pressure of 80/50 required physician office and emergency room visits; treatment for these events included fluids, potassium and antibiotics (unspecified). On 06Mar2021, the patient underwent COVID nasal swab which resulted to positive. The patient recovered from events fever, chills and migraine on 02Mar2021; and from high levels of histamine, hives on her back and chest and shortness of breath on 06Mar2021. The outcome of the events pneumonia, "blood pressure of 80/50" and "COVID-19 confirmed by positive COVID-19 test" was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Pyrexia, SARS-CoV-2 test, Urticaria
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; high levels of histamine; hives on back and chest; shortness of breath; blood pressure of 80/50; pneumonia; fever; chills; migraine; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6205, expiry date: unknown), via an unspecified route of administration in the right arm, on 26Feb2021 14:30, as single dose, for covid-19 immunization, at a health department. Medical history included known allergies to latex and egg whites. The patient did not have COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccines in 4 weeks. On 26Feb2021 at 17:00, 3 hours after the vaccine, the patient experienced fever, chills and migraine which went on for 4 nights (as reported). On 03Mar2021 (reported as "fifth night"), the patient started to have high levels of histamine, hives on her back and chest and shortness of breath for three days (as reported). In Mar2021 (reported as "by the weekend"), the patient went to urgent care, underwent x-ray of chest, and had pneumonia. In Mar2021 (reported as "Monday"), the patient came back with blood pressure of 80/50 and was sent to the emergency room (ER). It was reported that the events pneumonia, fever, chills, migraine, high levels of histamine, hives on back and chest, shortness of breath and blood pressure of 80/50 required physician office and emergency room visits; treatment for these events included fluids, potassium and antibiotics (unspecified). On 06Mar2021, the patient underwent COVID nasal swab which resulted to positive. The patient recovered from events fever, chills and migraine on 02Mar2021; and from high levels of histamine, hives on her back and chest and shortness of breath on 06Mar2021. The outcome of the events pneumonia, "blood pressure of 80/50" and "COVID-19 confirmed by positive COVID-19 test" was unknown.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Chest X-ray normal, Chorea, Cognitive disorder, Computerised tomogram head normal
Clinical narrative: admitted to our hospital with concerns for possible seizure; sudden stuttering of his voice; Pt began to experience sudden choreiform movements; experiencing changes in meditation and facial tics; inability to control his limbs.; This is a spontaneous report from a contactable other healthcare professional. An 88-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), intramuscular on 18Feb2021 10:00 as a single dose for covid-19 immunization. The patient's medical history included hypothyroidism, parkinson's disease and benign prostatic hyperplasia from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medications included carbidopa, levodopa (SINEMET); metoprolol (METOPROLOL); finasteride (FINASTERIDE); ergocalciferol (VIT D); and levothyroxine (LEVOTHYROXINE). The patient received the first dose of bnt162b2 on 28Jan2021 (lot: EL3249), intramuscularly for covid-19 immunization. On 28Feb2021, the patient began to experience sudden choreaform movements 10 days post 2nd dose of vaccine. Symptoms continued to progress and he was admitted in a hospital with concerns for possible seizures. Patient was displaying severe choreaform movement and inability to control his limbs. He was also experiencing changes in meditation and facial tics and sudden stuttering of his voice. The patient was treated for the events (not specified). The patient tested negative for Covid-19 on 14Mar2021 (via nasal swab). The outcome of the events was not recovered and patient remains hospitalized as of 15Mar2021.; Sender's Comments: Considering the plausible temporal association, (reportedly, the events occurred 10 days post 2nd dose of vaccine), a causative role of BNT162B2 for all reported events cannot be completely excluded. The contributory role of known Parkinsons disease cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count normal, Mental status changes, Metabolic function test, SARS-CoV-2 test negative, Troponin normal
Clinical narrative: admitted to our hospital with concerns for possible seizure; sudden stuttering of his voice; Pt began to experience sudden choreiform movements; experiencing changes in meditation and facial tics; inability to control his limbs.; This is a spontaneous report from a contactable other healthcare professional. An 88-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), intramuscular on 18Feb2021 10:00 as a single dose for covid-19 immunization. The patient's medical history included hypothyroidism, parkinson's disease and benign prostatic hyperplasia from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medications included carbidopa, levodopa (SINEMET); metoprolol (METOPROLOL); finasteride (FINASTERIDE); ergocalciferol (VIT D); and levothyroxine (LEVOTHYROXINE). The patient received the first dose of bnt162b2 on 28Jan2021 (lot: EL3249), intramuscularly for covid-19 immunization. On 28Feb2021, the patient began to experience sudden choreaform movements 10 days post 2nd dose of vaccine. Symptoms continued to progress and he was admitted in a hospital with concerns for possible seizures. Patient was displaying severe choreaform movement and inability to control his limbs. He was also experiencing changes in meditation and facial tics and sudden stuttering of his voice. The patient was treated for the events (not specified). The patient tested negative for Covid-19 on 14Mar2021 (via nasal swab). The outcome of the events was not recovered and patient remains hospitalized as of 15Mar2021.; Sender's Comments: Considering the plausible temporal association, (reportedly, the events occurred 10 days post 2nd dose of vaccine), a causative role of BNT162B2 for all reported events cannot be completely excluded. The contributory role of known Parkinsons disease cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urine analysis normal, Walking aid user
Clinical narrative: admitted to our hospital with concerns for possible seizure; sudden stuttering of his voice; Pt began to experience sudden choreiform movements; experiencing changes in meditation and facial tics; inability to control his limbs.; This is a spontaneous report from a contactable other healthcare professional. An 88-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), intramuscular on 18Feb2021 10:00 as a single dose for covid-19 immunization. The patient's medical history included hypothyroidism, parkinson's disease and benign prostatic hyperplasia from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medications included carbidopa, levodopa (SINEMET); metoprolol (METOPROLOL); finasteride (FINASTERIDE); ergocalciferol (VIT D); and levothyroxine (LEVOTHYROXINE). The patient received the first dose of bnt162b2 on 28Jan2021 (lot: EL3249), intramuscularly for covid-19 immunization. On 28Feb2021, the patient began to experience sudden choreaform movements 10 days post 2nd dose of vaccine. Symptoms continued to progress and he was admitted in a hospital with concerns for possible seizures. Patient was displaying severe choreaform movement and inability to control his limbs. He was also experiencing changes in meditation and facial tics and sudden stuttering of his voice. The patient was treated for the events (not specified). The patient tested negative for Covid-19 on 14Mar2021 (via nasal swab). The outcome of the events was not recovered and patient remains hospitalized as of 15Mar2021.; Sender's Comments: Considering the plausible temporal association, (reportedly, the events occurred 10 days post 2nd dose of vaccine), a causative role of BNT162B2 for all reported events cannot be completely excluded. The contributory role of known Parkinsons disease cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chorea, Dysphemia, Loss of control of legs, SARS-CoV-2 test, Seizure
Clinical narrative: admitted to our hospital with concerns for possible seizure; sudden stuttering of his voice; Pt began to experience sudden choreiform movements; experiencing changes in meditation and facial tics; inability to control his limbs.; This is a spontaneous report from a contactable other healthcare professional. An 88-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), intramuscular on 18Feb2021 10:00 as a single dose for covid-19 immunization. The patient's medical history included hypothyroidism, parkinson's disease and benign prostatic hyperplasia from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medications included carbidopa, levodopa (SINEMET); metoprolol (METOPROLOL); finasteride (FINASTERIDE); ergocalciferol (VIT D); and levothyroxine (LEVOTHYROXINE). The patient received the first dose of bnt162b2 on 28Jan2021 (lot: EL3249), intramuscularly for covid-19 immunization. On 28Feb2021, the patient began to experience sudden choreaform movements 10 days post 2nd dose of vaccine. Symptoms continued to progress and he was admitted in a hospital with concerns for possible seizures. Patient was displaying severe choreaform movement and inability to control his limbs. He was also experiencing changes in meditation and facial tics and sudden stuttering of his voice. The patient was treated for the events (not specified). The patient tested negative for Covid-19 on 14Mar2021 (via nasal swab). The outcome of the events was not recovered and patient remains hospitalized as of 15Mar2021.; Sender's Comments: Considering the plausible temporal association, (reportedly, the events occurred 10 days post 2nd dose of vaccine), a causative role of BNT162B2 for all reported events cannot be completely excluded. The contributory role of known Parkinsons disease cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tic
Clinical narrative: admitted to our hospital with concerns for possible seizure; sudden stuttering of his voice; Pt began to experience sudden choreiform movements; experiencing changes in meditation and facial tics; inability to control his limbs.; This is a spontaneous report from a contactable other healthcare professional. An 88-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), intramuscular on 18Feb2021 10:00 as a single dose for covid-19 immunization. The patient's medical history included hypothyroidism, parkinson's disease and benign prostatic hyperplasia from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medications included carbidopa, levodopa (SINEMET); metoprolol (METOPROLOL); finasteride (FINASTERIDE); ergocalciferol (VIT D); and levothyroxine (LEVOTHYROXINE). The patient received the first dose of bnt162b2 on 28Jan2021 (lot: EL3249), intramuscularly for covid-19 immunization. On 28Feb2021, the patient began to experience sudden choreaform movements 10 days post 2nd dose of vaccine. Symptoms continued to progress and he was admitted in a hospital with concerns for possible seizures. Patient was displaying severe choreaform movement and inability to control his limbs. He was also experiencing changes in meditation and facial tics and sudden stuttering of his voice. The patient was treated for the events (not specified). The patient tested negative for Covid-19 on 14Mar2021 (via nasal swab). The outcome of the events was not recovered and patient remains hospitalized as of 15Mar2021.; Sender's Comments: Considering the plausible temporal association, (reportedly, the events occurred 10 days post 2nd dose of vaccine), a causative role of BNT162B2 for all reported events cannot be completely excluded. The contributory role of known Parkinsons disease cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood creatine abnormal, Blood urea increased, C-reactive protein abnormal, Chest X-ray, Dizziness
Clinical narrative: back of head and neck hurts, felt like whiplash; back of head and neck hurts, felt like whiplash; Headache/ back of head and neck hurts/ walking too much and looking up/down and left/right causes headache; Dizziness; blurry vision; sensation of eyes wanting to cross; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiry date were unknown), via an unspecified route of administration in the left arm on 11Mar2021 13:00 (at 43 years old) at a SINGLE DOSE for COVID-19 immunization. The patient's medical history included glaucoma, asthma, and allergies to topical iodine, penicillin, and latex, all from an unknown date and unknown if ongoing. The patient was not pregnant. Concomitant medications included brimonidine tartrate (ALPHAGAN), brinzolamide (AZOPT), latanoprost (XALATAN) and an unspecified Inhaler; therapy dates and indications were unknown for all. The patient took these medications within two weeks before the event onset. The patient did not receive other vaccination within 4 weeks prior to the BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. It was reported that on day 1 (11Mar2021), the patient experienced dizziness, blurry vision, and sensation of eyes wanting to cross. On day 2 (12Mar2021), the patient experienced headache, blurry vision, and sensation of eyes wanting to cross. On day 3 (13Mar2021), patient experienced back of head and neck hurts, felt like whiplash; walking too much and looking up/down and left/right causes headache. On day 4, the symptoms from day 3 continued. No treatment was received in response to the events. The adverse events involved hospitalization. The outcome of the events was not recovered.  Information on batch/lot number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Full blood count, Head discomfort, Headache, Magnetic resonance imaging head
Clinical narrative: back of head and neck hurts, felt like whiplash; back of head and neck hurts, felt like whiplash; Headache/ back of head and neck hurts/ walking too much and looking up/down and left/right causes headache; Dizziness; blurry vision; sensation of eyes wanting to cross; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiry date were unknown), via an unspecified route of administration in the left arm on 11Mar2021 13:00 (at 43 years old) at a SINGLE DOSE for COVID-19 immunization. The patient's medical history included glaucoma, asthma, and allergies to topical iodine, penicillin, and latex, all from an unknown date and unknown if ongoing. The patient was not pregnant. Concomitant medications included brimonidine tartrate (ALPHAGAN), brinzolamide (AZOPT), latanoprost (XALATAN) and an unspecified Inhaler; therapy dates and indications were unknown for all. The patient took these medications within two weeks before the event onset. The patient did not receive other vaccination within 4 weeks prior to the BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. It was reported that on day 1 (11Mar2021), the patient experienced dizziness, blurry vision, and sensation of eyes wanting to cross. On day 2 (12Mar2021), the patient experienced headache, blurry vision, and sensation of eyes wanting to cross. On day 3 (13Mar2021), patient experienced back of head and neck hurts, felt like whiplash; walking too much and looking up/down and left/right causes headache. On day 4, the symptoms from day 3 continued. No treatment was received in response to the events. The adverse events involved hospitalization. The outcome of the events was not recovered.  Information on batch/lot number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Neck pain, Vision blurred
Clinical narrative: back of head and neck hurts, felt like whiplash; back of head and neck hurts, felt like whiplash; Headache/ back of head and neck hurts/ walking too much and looking up/down and left/right causes headache; Dizziness; blurry vision; sensation of eyes wanting to cross; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiry date were unknown), via an unspecified route of administration in the left arm on 11Mar2021 13:00 (at 43 years old) at a SINGLE DOSE for COVID-19 immunization. The patient's medical history included glaucoma, asthma, and allergies to topical iodine, penicillin, and latex, all from an unknown date and unknown if ongoing. The patient was not pregnant. Concomitant medications included brimonidine tartrate (ALPHAGAN), brinzolamide (AZOPT), latanoprost (XALATAN) and an unspecified Inhaler; therapy dates and indications were unknown for all. The patient took these medications within two weeks before the event onset. The patient did not receive other vaccination within 4 weeks prior to the BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. It was reported that on day 1 (11Mar2021), the patient experienced dizziness, blurry vision, and sensation of eyes wanting to cross. On day 2 (12Mar2021), the patient experienced headache, blurry vision, and sensation of eyes wanting to cross. On day 3 (13Mar2021), patient experienced back of head and neck hurts, felt like whiplash; walking too much and looking up/down and left/right causes headache. On day 4, the symptoms from day 3 continued. No treatment was received in response to the events. The adverse events involved hospitalization. The outcome of the events was not recovered.  Information on batch/lot number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Neck pain, Post-traumatic neck syndrome, Strabismus
Clinical narrative: back of head and neck hurts, felt like whiplash; back of head and neck hurts, felt like whiplash; Headache/ back of head and neck hurts/ walking too much and looking up/down and left/right causes headache; Dizziness; blurry vision; sensation of eyes wanting to cross; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiry date were unknown), via an unspecified route of administration in the left arm on 11Mar2021 13:00 (at 43 years old) at a SINGLE DOSE for COVID-19 immunization. The patient's medical history included glaucoma, asthma, and allergies to topical iodine, penicillin, and latex, all from an unknown date and unknown if ongoing. The patient was not pregnant. Concomitant medications included brimonidine tartrate (ALPHAGAN), brinzolamide (AZOPT), latanoprost (XALATAN) and an unspecified Inhaler; therapy dates and indications were unknown for all. The patient took these medications within two weeks before the event onset. The patient did not receive other vaccination within 4 weeks prior to the BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. It was reported that on day 1 (11Mar2021), the patient experienced dizziness, blurry vision, and sensation of eyes wanting to cross. On day 2 (12Mar2021), the patient experienced headache, blurry vision, and sensation of eyes wanting to cross. On day 3 (13Mar2021), patient experienced back of head and neck hurts, felt like whiplash; walking too much and looking up/down and left/right causes headache. On day 4, the symptoms from day 3 continued. No treatment was received in response to the events. The adverse events involved hospitalization. The outcome of the events was not recovered.  Information on batch/lot number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: back of head and neck hurts, felt like whiplash; back of head and neck hurts, felt like whiplash; Headache/ back of head and neck hurts/ walking too much and looking up/down and left/right causes headache; Dizziness; blurry vision; sensation of eyes wanting to cross; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiry date were unknown), via an unspecified route of administration in the left arm on 11Mar2021 13:00 (at 43 years old) at a SINGLE DOSE for COVID-19 immunization. The patient's medical history included glaucoma, asthma, and allergies to topical iodine, penicillin, and latex, all from an unknown date and unknown if ongoing. The patient was not pregnant. Concomitant medications included brimonidine tartrate (ALPHAGAN), brinzolamide (AZOPT), latanoprost (XALATAN) and an unspecified Inhaler; therapy dates and indications were unknown for all. The patient took these medications within two weeks before the event onset. The patient did not receive other vaccination within 4 weeks prior to the BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. It was reported that on day 1 (11Mar2021), the patient experienced dizziness, blurry vision, and sensation of eyes wanting to cross. On day 2 (12Mar2021), the patient experienced headache, blurry vision, and sensation of eyes wanting to cross. On day 3 (13Mar2021), patient experienced back of head and neck hurts, felt like whiplash; walking too much and looking up/down and left/right causes headache. On day 4, the symptoms from day 3 continued. No treatment was received in response to the events. The adverse events involved hospitalization. The outcome of the events was not recovered.  Information on batch/lot number has been requested.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure decreased, Blood thyroid stimulating hormone abnormal, Chest X-ray, Chills, Dysphagia
Clinical narrative: sore arm; chills; fever; headache; nausea; painful swallowing; enlarged thyroid (the right lobe); undetectable levels of TSH- this is consistent with acute thyroiditis; undetectable levels of TSH- this is consistent with acute thyroiditis; This is a spontaneous report from a contactable consumer (patient). A 57-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 27Feb2021 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation. Medical history included food reactions to shrimps, crabs, lobsters- and occasionally to pineapples, avocado and eggs; reactions to penicillin, sulfa- type medications. Other medical history: none. No covid prior vaccination. Historical Vaccine at 57 years old included first single dose of BNT162B2 (lot number=EL9264) on 06Feb2021 04:30 PM, vaccine location=Left arm for COVID-19 immunization; after got the first dose, the patient experienced fever, headaches, sore arm- however they went away in a couple of days. No pregnant. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. The patient experienced sore arm, chills, fever, headache, nausea, painful swallowing, enlarged thyroid, undetectable levels of tsh- this is consistent with acute thyroiditis on 27Feb2021 22:00. Adverse event: Soon after got the second dose, the patient was feeling a variety of side effects sore arm, chills, fever, headache, nausea, painful swallowing- the last three symptoms continued until she saw her doctor 12 days later. The blood tests revealed undetectable levels of TSH- this is consistent with acute thyroiditis. The patient had to get to ER to seek immediate medical attention. At the Hospital he was further tested (blood, urine, PCR for COVID, X ray of the lungs) and also underwent ultrasound of the thyroid. The scan showed that an enlarged thyroid (the right lobe). The events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization. No day's hospitalization (on an unknown date): 1. He was treated with anti inflammatory, anti nausea meds along with a beta blocker. Shortly afterwards, he was given IV fluids in order to stabilize my blood pressure. He was released from the hospital in the evening of the following day. Currently he was Advil, Propranolol, and Zofran. AE treatment: Ibuprofen, Anti nausea drugs, Propranolol, IV fluid. The patient underwent lab tests and procedures which included blood test: ndetectable levels of tsh on an unknown date; blood test: unknown results on 12Mar2021; Covid test post vaccination (Nasal Swab PCR) on 12Mar2021: Negative; ultrasound thyroid: enlarged thyroid (the right lobe) on 12Mar2021; urine: unknown results on 12Mar2021; X ray of the lungs: unknown results on 12Mar2021. The event outcome was recovering.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Emotional distress, Fatigue, Headache, Heart rate increased, Hyperthyroidism
Clinical narrative: sore arm; chills; fever; headache; nausea; painful swallowing; enlarged thyroid (the right lobe); undetectable levels of TSH- this is consistent with acute thyroiditis; undetectable levels of TSH- this is consistent with acute thyroiditis; This is a spontaneous report from a contactable consumer (patient). A 57-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 27Feb2021 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation. Medical history included food reactions to shrimps, crabs, lobsters- and occasionally to pineapples, avocado and eggs; reactions to penicillin, sulfa- type medications. Other medical history: none. No covid prior vaccination. Historical Vaccine at 57 years old included first single dose of BNT162B2 (lot number=EL9264) on 06Feb2021 04:30 PM, vaccine location=Left arm for COVID-19 immunization; after got the first dose, the patient experienced fever, headaches, sore arm- however they went away in a couple of days. No pregnant. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. The patient experienced sore arm, chills, fever, headache, nausea, painful swallowing, enlarged thyroid, undetectable levels of tsh- this is consistent with acute thyroiditis on 27Feb2021 22:00. Adverse event: Soon after got the second dose, the patient was feeling a variety of side effects sore arm, chills, fever, headache, nausea, painful swallowing- the last three symptoms continued until she saw her doctor 12 days later. The blood tests revealed undetectable levels of TSH- this is consistent with acute thyroiditis. The patient had to get to ER to seek immediate medical attention. At the Hospital he was further tested (blood, urine, PCR for COVID, X ray of the lungs) and also underwent ultrasound of the thyroid. The scan showed that an enlarged thyroid (the right lobe). The events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization. No day's hospitalization (on an unknown date): 1. He was treated with anti inflammatory, anti nausea meds along with a beta blocker. Shortly afterwards, he was given IV fluids in order to stabilize my blood pressure. He was released from the hospital in the evening of the following day. Currently he was Advil, Propranolol, and Zofran. AE treatment: Ibuprofen, Anti nausea drugs, Propranolol, IV fluid. The patient underwent lab tests and procedures which included blood test: ndetectable levels of tsh on an unknown date; blood test: unknown results on 12Mar2021; Covid test post vaccination (Nasal Swab PCR) on 12Mar2021: Negative; ultrasound thyroid: enlarged thyroid (the right lobe) on 12Mar2021; urine: unknown results on 12Mar2021; X ray of the lungs: unknown results on 12Mar2021. The event outcome was recovering.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Nausea, Pain in extremity, Pyrexia, Similar reaction on previous exposure to drug
Clinical narrative: sore arm; chills; fever; headache; nausea; painful swallowing; enlarged thyroid (the right lobe); undetectable levels of TSH- this is consistent with acute thyroiditis; undetectable levels of TSH- this is consistent with acute thyroiditis; This is a spontaneous report from a contactable consumer (patient). A 57-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 27Feb2021 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation. Medical history included food reactions to shrimps, crabs, lobsters- and occasionally to pineapples, avocado and eggs; reactions to penicillin, sulfa- type medications. Other medical history: none. No covid prior vaccination. Historical Vaccine at 57 years old included first single dose of BNT162B2 (lot number=EL9264) on 06Feb2021 04:30 PM, vaccine location=Left arm for COVID-19 immunization; after got the first dose, the patient experienced fever, headaches, sore arm- however they went away in a couple of days. No pregnant. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. The patient experienced sore arm, chills, fever, headache, nausea, painful swallowing, enlarged thyroid, undetectable levels of tsh- this is consistent with acute thyroiditis on 27Feb2021 22:00. Adverse event: Soon after got the second dose, the patient was feeling a variety of side effects sore arm, chills, fever, headache, nausea, painful swallowing- the last three symptoms continued until she saw her doctor 12 days later. The blood tests revealed undetectable levels of TSH- this is consistent with acute thyroiditis. The patient had to get to ER to seek immediate medical attention. At the Hospital he was further tested (blood, urine, PCR for COVID, X ray of the lungs) and also underwent ultrasound of the thyroid. The scan showed that an enlarged thyroid (the right lobe). The events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization. No day's hospitalization (on an unknown date): 1. He was treated with anti inflammatory, anti nausea meds along with a beta blocker. Shortly afterwards, he was given IV fluids in order to stabilize my blood pressure. He was released from the hospital in the evening of the following day. Currently he was Advil, Propranolol, and Zofran. AE treatment: Ibuprofen, Anti nausea drugs, Propranolol, IV fluid. The patient underwent lab tests and procedures which included blood test: ndetectable levels of tsh on an unknown date; blood test: unknown results on 12Mar2021; Covid test post vaccination (Nasal Swab PCR) on 12Mar2021: Negative; ultrasound thyroid: enlarged thyroid (the right lobe) on 12Mar2021; urine: unknown results on 12Mar2021; X ray of the lungs: unknown results on 12Mar2021. The event outcome was recovering.